Sickle Cell Disease (SCD) is a global health challenge that affects millions of people worldwide. Despite significant advances in understanding the ...

Analyst Ed Arce from H.C. Wainwright maintained a Buy rating on Akebia Therapeutics (AKBA – Research Report) and keeping the price target at ...

Myelodysplastic syndromes (MDS) are marked by ineffective hematopoiesis and dysplasia, which elevate the risk of progression to acute myeloid leukemia (AML). The inflammatory environment in MDS alters ...

Bitopertin is an investigational agent and is not approved for use as a therapy in any jurisdiction worldwide. Disc obtained global rights to bitopertin under a license agreement from Roche in May ...

Proc. Dec. 1965 Conf. Bone Marrow Transplantation and Radiation Recovery. Gurney, C. W., “The Regulation of Hemopoietic Stem Cell Compartment”, paper presented at Dec. 1965 Conf. Bone Marrow ...